美国食品药品监督管理局（FDA）于2025年5月16日批准了首个用于辅助诊断阿尔茨海默病（AD）的血液检测试剂盒——Lumipulse G pTau217/β-淀粉样蛋白1-42血浆比值检测试剂盒，由日本富士莱必欧诊断公司（Fujirebio ...

[10] Janakiraman, V. (2025). Listeriosis in Pregnancy: Diagnosis, Treatment, and Prevention. Reviews in Obstetrics and ...

The agency noted that the supplements, taken orally with tablets or drops, are not approved by the FDA. FDA Commissioner Marty Makary also suggested the supplements may alter a child's gut microbiome, ...